M. E. Garza
M. E. Garza
Send Message
M. E. Garza
Stop FollowingM. E. Garza
View as an RSS Feed
View M. E. Garza's Articles BY TICKER:
ACAR.OB,
ACCP.OB,
ALKS,
ALTH,
ALXA,
AMPE,
AMRN,
ARIA,
ARNA,
ARRY,
ASTM,
ASTX,
AVEO,
AVNR,
BCRX,
BLRX,
BPAX,
CBLI,
CCEL.OB,
CDXC.OB,
CLDA,
CLRT,
CLSN,
CNDO,
CORT,
CRIS,
CTIC,
CVM,
CYTR,
DCTH,
DEPO,
ECTE,
EPCT.PK,
EPIX.PK,
EXEL,
FURX,
GALE,
GSK,
GTHP.OB,
HALO,
HEB,
HLF,
IBIO,
IDIX,
IMMY,
IMUC,
INCY,
INHX,
IPCI,
KERX,
KVPBQ.PK,
LGND,
MDGN,
MEDX,
MNTA,
MSTX,
NAVB,
NBIX,
NBS,
NEPH.OB,
NEPT,
NPSP,
NVAX,
NVLT.OB,
NWBO,
OCLS,
OMPI,
ONCS.OB,
ONCY,
OPK,
OXGN,
PBTH,
PGNX,
PLX,
POZN,
PPHM,
PSTI,
PVCT.OB,
QGEN,
RGEN,
RNN,
RXPC.PK,
SGEN,
SIGA,
SLXP,
SNWV.OB,
SPPI,
SYN,
TDLP.OB,
THLD,
THRX,
TKMR,
TSPT,
VICL,
XOMA,
YMI,
ZLCS
- CEL-SCI CEO's Bullish Biotech Play
- Oculus's New Product Can Tap into Several Billion Dollar Markets
- Nephros Continues to Rise Ahead of FDA Decisions
- Positive News Ahead for Oculus Innovative Sciences
- CryoCell Has a Future to Bank On
- More Positive Developments for Spectrum Pharma
- CEL-SCI's Flu Work: Diligent Preparation, Promising Results
- Key Developments for Spectrum Pharma, Human Genome Sciences and Hemispherx Biopharma
- Shares of HGSI Up Big in Anticipation of Clinical Trials Update
- Is the Market About to Rally or Correct?
- Big Lineup of Healthcare Stocks Crack the Russell 3000 Index
- Oculus CEO: Inaccurate Reports Becoming a Safety Issue
- Big Movers in Healthcare - JAZZ, HEB, MNTA, MBLX and OCLS
- Russell Indexing Reshuffle Moves Healthcare Stocks: CXM, CTIC, HEB, CPD
- Today's Healthcare Market Movers: SCLN, HEB, SPPI, CRTX, KV.A
- Health Care Market Movers: SMMX, INSM, ADLS, HEB, ACUR and HALO
- Medarex's 'Holy Grail' Against Prostate Cancer Causes Surge in Share Price
- Healthcare Stocks Continue to Rise
- Adult Stem Cell Drugs and Therapies Are the Next Big Market
- Healthcare Stocks Sluggish as Some Say Recent Rally Is Over
- 6 Healthcare Stocks to Watch
- Healthcare Stocks: Favorable Reaction to Treasury Markets
- Wednesday's Healthcare Market Movers
- Sequenom's Speculative Shares Lift Off on Tuesday
- Human Genome Sciences, GlaxoSmithKline: Diabetes Data Looks Good
- Bio Medical Stock Sector is Where the Action Is
- Biggest Health Care Winners Become Biggest Losers After Friday's Market Action
- Friday's BioPlay: Xoma Ltd.
- Novavax Soars After Influenza Vaccine Deal
- Human Genome Sciences: Rising on Both Good and Bad News
- Cell Therapeutics Likely to Move Higher on Significant Cancer Study News
